Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Gene-Edited Organ Transplants, Long COVID Therapy, and New FDA Food Labeling Standards
In this episode, Dr. Chi-Ming Chow opens with a welcome and introduction to the day's topics. He discusses the pioneering gene-edited pig kidney transplant and its implications for xenotransplantation. The episode explores the use of cognitive behavioral therapy in managing long COVID symptoms. Dr. Chow examines Alberta's new pay model for family doctors, highlighting potential impacts on healthcare delivery. He reviews the FDA's updated food labeling standards and criteria for "healthy" labeling. The episode also addresses a recent surge in US healthcare spending and the FDA's action against knockoff obesity and diabetes drugs. The episode concludes with a sign-off.
Key Points
- The successful gene-edited pig kidney transplant at NYU Langone Health marks a significant advancement in xenotransplantation, potentially addressing the organ shortage crisis.
- A new study from Norway shows that cognitive and behavioral therapy can significantly improve physical function in individuals suffering from long COVID, offering a promising treatment approach.
- The FDA has updated its criteria for labeling foods as "healthy," introducing new limits on saturated fat, sodium, and added sugars to better align with contemporary nutritional science.
Chapters
| 0:00 | |
| 0:25 | |
| 3:45 | |
| 6:48 | |
| 10:51 | |
| 13:59 | |
| 16:38 | |
| 23:07 |
Transcript
Loading transcript...
- / -